Rolf KAISER;Frank HILBERG;David SHAPIRO;Martin Friedrich STEFANIC
发明人:
Martin Friedrich STEFANIC,Frank HILBERG,Rolf KAISER,David SHAPIRO
申请号：
US13869139
公开号：
US20130237549A1
申请日:
2013.04.24
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to a pharmaceutical combination which may be useful for the treatment of diseases which involve cell proliferation, which involve migration or apoptosis of myeloma cells, which involve angiogenesis or which involve fibrosis. The invention also relates to a method for the treatment of said diseases, comprising simultaneous, separate or sequential administration of effective amounts of specific active compounds and/or co-treatment with radiation therapy, in a ratio which provides an additive and synergistic effect, and to the combined use of these specific compounds and/or radiotherapy for the manufacture of corresponding pharmaceutical combination preparations.
